Industrials, Financials, Technology May 18, 2022 03:55 PM (GMT+8) · EqualOcean
Tonghua Dongbao announced that after receiving the approval notice of three phase I clinical trials of soluble glargine lispro double insulin injection (thdb0207 injection) issued by the German regulatory authority (bfarm), the company has started the phase I clinical trial in Germany, and recently successfully completed the first subject of ct046-ado05 trial.